Top compounds associated with response to SPATC1L


Feature Type Standardized
Nominal ANOVA
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.5
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.027 0.5
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.021 0.5
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.5
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA barasertib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA PHA-665752 GDSC1000 pan-cancer AAC 0.036 0.5
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC -0.03 0.5
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.024 0.5
Download CSV